Stocks-INMD-Inmode Ltd

INMD Inmode Ltd

36.20 -0.35 (-0.96%)
Delayed Prices By NASDAQ, in USD Market Closed
3.34% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
Day’s Range
52W Range
Volume (3M)
Price-Earnings Ratio

Inmode Ltd Latest News

View All
Pinned Post
eToro Team
🎉 Here’s a little preview introducing 16 YEARS of INVESTING on eToro 😏🤑 With love, - The eToro Team
Like CommentShare
Show more comments2 of 75
5 replies
Top Discussions
Cristian Adam
Why did I increase my stake in $INMD (Inmode Ltd) ? They have been posting solid revenue growth and showing strong profits for years now, yet they seem to be priced like a stable growth company instead of a high growth one. $INMD isn't overburdened in debt, they are increasing profits quarterly,... Show More
Like CommentShare
1 reply
4 replies
Henrik Bilevits
𝗣𝗘𝗥𝗙𝗢𝗥𝗠𝗔𝗡𝗖𝗘 𝗝𝗔𝗡𝗨𝗔𝗥𝗬 𝟮𝟬𝟮𝟯 The month of January was a relief compared to 2022, let's hope it continues in February. 𝗠𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 January: +9.24% 𝗠𝘆 𝗿𝗲𝘀𝘂𝗹𝘁𝘀 𝗰𝗼𝗺𝗽𝗮𝗿𝗲𝗱 𝘁𝗼: ✅ SPX500 January: +6.18% ❌ NSDQ100 January: +10,62% ✅ Warren Buffet January:... Show More
Like CommentShare
Good morning investors, today I bring several reflections on the current market, although inflation is falling, it is still far from how the Fed wants it, in addition the data and metrics of the US favor that the Fed continues to raise interest rates. you could say that this is already discounted on... Show More
Like CommentShare
4 replies
Andrea Aldea
🔹 𝙅𝙖𝙣𝙪𝙖𝙧𝙮 𝟭𝟳, 𝟐𝟎𝟐𝟯 🔹 𝑫𝑨𝑰𝑳𝒀 𝑼𝑷𝑫𝑨𝑻𝑬 🔹 🔹 U.S. equities began the shortened trading week mixed as more corporate earnings reports rolled in. The Dow lost almost 400 points, sent lower by concerns about profits at Goldman Sachs (GS) and The Travelers Companies (TRV). The S&P... Show More
Like CommentShare
2 replies
David Haskey
United Kingdom
$INMD (Inmode Ltd) recently reported unaudited 2022 sales figures that reached between $453.9 million and $454.1 million. The global market for cosmetic surgery and procedures reached a stunning $63.4 billion in 2021, and it's expected to climb by 9.6% annually through 2030. $INMD is gaining market... Show More
Like CommentShare

About Inmode Ltd

InMode is an international healthcare company with its headquarters in Yokneam, Israel. Founded in 2008, the company focusses on the design, development, and manufacture of minimally-invasive aesthetic medical products. Healthcare products developed by InMode harness novel radio frequency technology, and are based on its proprietary radiofrequency-assisted lipolysis and deep subdermal fractional radiofrequency technologies. InMode trades on the NASDAQ GS under the ticker INMD. In 2020, the INMD price chart showed a 52-week low of $13.14 and a 52-week high of $58.76, with a market cap of $1.31bn. In September 2020 InMode announced approval for a share repurchase programme of up to 1 million ordinary shares. The company produces state-of-the-art devices to support aesthetic treatments for the face, body and skin — including plastic surgery and dermatology — using mainly non-invasive and minimally-invasive options. InMode strives to use technology to enable new and emerging surgical procedures, and to improve existing treatments. The organisation mainly serves healthcare providers in various specialities across the globe, and regularly hosts seminars and attends conferences to raise awareness around its unique technologies. Diversify your investment portfolio today by buying INMD stock. You can also track the INMD share price by adding this instrument to your eToro watchlist for instant updates.
Yokneam, Tel Aviv, US
Moshe Mizrahy, MBA
Show More

Upcoming Earnings

Inmode Ltd Q4 2022 earnings report is expected to be released before market open

Analyst Forecast

Strong Buy
Price Target

People Also Bought